These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29350067)

  • 1. Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease.
    Fornasari BE; Ronchi G; Pascal D; Visigalli D; Capodivento G; Nobbio L; Perroteau I; Schenone A; Geuna S; Gambarotta G
    Exp Biol Med (Maywood); 2018 Feb; 243(4):370-374. PubMed ID: 29350067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies.
    Fledrich R; Akkermann D; Schütza V; Abdelaal TA; Hermes D; Schäffner E; Soto-Bernardini MC; Götze T; Klink A; Kusch K; Krueger M; Kungl T; Frydrychowicz C; Möbius W; Brück W; Mueller WC; Bechmann I; Sereda MW; Schwab MH; Nave KA; Stassart RM
    Nat Commun; 2019 Apr; 10(1):1467. PubMed ID: 30931926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A.
    Massa R; Palumbo C; Cavallaro T; Panico MB; Bei R; Terracciano C; Rizzuto N; Bernardi G; Modesti A
    Muscle Nerve; 2006 Mar; 33(3):342-9. PubMed ID: 16307437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot-Marie-Tooth disease 4H.
    El-Bazzal L; Ghata A; Estève C; Gadacha J; Quintana P; Castro C; Roeckel-Trévisiol N; Lembo F; Lenfant N; Mégarbané A; Borg JP; Lévy N; Bartoli M; Poitelon Y; Roubertoux PL; Delague V; Bernard-Marissal N
    Brain; 2023 May; 146(5):1844-1858. PubMed ID: 36314052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
    Sociali G; Visigalli D; Prukop T; Cervellini I; Mannino E; Venturi C; Bruzzone S; Sereda MW; Schenone A
    Neurobiol Dis; 2016 Nov; 95():145-57. PubMed ID: 27431093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A.
    Fledrich R; Stassart RM; Klink A; Rasch LM; Prukop T; Haag L; Czesnik D; Kungl T; Abdelaal TA; Keric N; Stadelmann C; Brück W; Nave KA; Sereda MW
    Nat Med; 2014 Sep; 20(9):1055-61. PubMed ID: 25150498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neuregulin1/ErbB system is selectively regulated during peripheral nerve degeneration and regeneration.
    Ronchi G; Haastert-Talini K; Fornasari BE; Perroteau I; Geuna S; Gambarotta G
    Eur J Neurosci; 2016 Feb; 43(3):351-64. PubMed ID: 26061116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S; Scherer SS; Nave KA; Suter U
    J Neurosci Res; 2002 Feb; 67(4):443-9. PubMed ID: 11835311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
    Chumakov I; Milet A; Cholet N; Primas G; Boucard A; Pereira Y; Graudens E; Mandel J; Laffaire J; Foucquier J; Glibert F; Bertrand V; Nave KA; Sereda MW; Vial E; Guedj M; Hajj R; Nabirotchkin S; Cohen D
    Orphanet J Rare Dis; 2014 Dec; 9():201. PubMed ID: 25491744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Pathogenesis of Charcot-Marie-Tooth Disease Type 1A Using Patient-Specific iPSCs.
    Shi L; Huang L; He R; Huang W; Wang H; Lai X; Zou Z; Sun J; Ke Q; Zheng M; Lu X; Pei Z; Su H; Xiang AP; Li W; Yao X
    Stem Cell Reports; 2018 Jan; 10(1):120-133. PubMed ID: 29276154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFβ4 alleviates the phenotype of Charcot-Marie-Tooth disease type 1A.
    Jeon H; Jang SY; Kwak G; Yi YW; You MH; Park NY; Jo JH; Yang JW; Jang HJ; Jeong SY; Moon SK; Doo HM; Nahm M; Kim D; Chang JW; Choi BO; Hong YB
    Brain; 2023 Sep; 146(9):3608-3615. PubMed ID: 37143322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
    Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
    Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy.
    Nobbio L; Fiorese F; Vigo T; Cilli M; Gherardi G; Grandis M; Melcangi RC; Mancardi G; Abbruzzese M; Schenone A
    J Neuropathol Exp Neurol; 2009 May; 68(5):441-55. PubMed ID: 19525893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Human Tonsil-Derived Mesenchymal Stem Cells into Schwann-Like Cells Improves Neuromuscular Function in a Mouse Model of Charcot-Marie-Tooth Disease Type 1A.
    Park S; Jung N; Myung S; Choi Y; Chung KW; Choi BO; Jung SC
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30110925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of peripheral myelin protein 22 in onion bulbs and Schwann cells of biopsied nerves from patients with Charcot-Marie-Tooth disease type 1A.
    Nishimura T; Yoshikawa H; Fujimura H; Sakoda S; Yanagihara T
    Acta Neuropathol; 1996 Nov; 92(5):454-60. PubMed ID: 8922056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy.
    Hantke J; Carty L; Wagstaff LJ; Turmaine M; Wilton DK; Quintes S; Koltzenburg M; Baas F; Mirsky R; Jessen KR
    Brain; 2014 Nov; 137(Pt 11):2922-37. PubMed ID: 25216747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Neuregulin1 Down-Regulates Myelination Genes in Schwann Cells.
    El Soury M; Fornasari BE; Morano M; Grazio E; Ronchi G; Incarnato D; Giacobini M; Geuna S; Provero P; Gambarotta G
    Front Mol Neurosci; 2018; 11():157. PubMed ID: 29867349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A.
    Nobbio L; Visigalli D; Mannino E; Fiorese F; Kassack MU; Sturla L; Prada V; De Flora A; Zocchi E; Bruzzone S; Schenone A
    J Cell Biochem; 2014 Jan; 115(1):161-7. PubMed ID: 23959806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.